All News Telesis Bio, Inc.

Equities

TBIO

US1920032000

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-17 pm EDT			5-day change	1st Jan Change
4.5 ^USD	+3.45%		-12.11%	-37.34%

May. 09	Earnings Flash (TBIO) TELESIS BIO Reports Q1 Revenue $3.4M	MT
May. 09	Telesis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Telesis Bio: Q1 Earnings Snapshot	May. 09	AQ
Earnings Flash (TBIO) TELESIS BIO Reports Q1 Revenue $3.4M	May. 09	MT
Telesis Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
Telesis Bio Reports First Quarter 2024 Financial Results	May. 09	GL
Telesis Bio Announces Reverse Stock Split	May. 06	GL
Telesis Bio Inc. announces strategic focus on game-changing Gibson SOLA enzymatic DNA synthesis (EDS) platform and BioXp mRNA solutions and announces new leadership	Apr. 18	GL
Telesis Bio, Inc. Announces Appointment of Eric Esser to the Board of Directors	Apr. 18	CI
Telesis Bio Inc. Announces Strategic Focus on Game-Changing Gibson Sola Enzymatic DNA Synthesis Platform and BioXp mRNA Solutions	Apr. 18	CI
Telesis Bio, Inc. Announces Chief Executive Officer Changes	Apr. 18	CI
Telesis Bio : Shareholder Meeting - Form 8-K	Apr. 08	PU
Telesis Bio: Q4 Earnings Snapshot	Mar. 28	AQ
Earnings Flash (TBIO) TELESIS BIO Reports Q4 Revenue $7M	Mar. 28	MT
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results	Mar. 28	GL
Telesis Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 28	CI
Telesis Bio, Inc. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023	Mar. 28	CI
Stocks Making Waves: Insights into Key Developments and Potential VTAK, TBIO, OCEA, ONMD, KZIA	Feb. 27	AQ
Telesis Bio, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 26	CI
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results	Feb. 26	GL
Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results	Feb. 26	AQ
Thinking about buying stock in Telesis Bio, Sellas Life Sciences, Mitek Systems, Monopar Therapeutics, or Inpixon?	Feb. 23	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Telesis Bio, Inc.

Equities

TBIO

US1920032000

All News

Filters